# An in-vivo experimental evaluation of the efficacy of fish-derived antimicrobial peptides against multidrug-resistant Pseudomonas aeruginosa

**Authors:** Agharid Ali Al-Rasheed, Bashiru Garba, Kareem Obayes Handool, Karim Alwan Al-Jashamy, Mohamed Naji Ahmed Odhah, Najib Isse Dirie, Hassan Mohd Daud

PMC · DOI: 10.11604/pamj.2023.46.112.38578 · The Pan African Medical Journal · 2023-12-21

## TL;DR

This study shows that antimicrobial peptides from climbing perch fish can effectively reduce multidrug-resistant Pseudomonas aeruginosa infections in mice.

## Contribution

The study experimentally evaluates fish-derived antimicrobial peptides as a potential alternative to antibiotics for treating drug-resistant infections.

## Key findings

- AMPs from climbing perch reduced mortality from 100% to 25% in mice infected with multidrug-resistant Pseudomonas aeruginosa.
- AMP treatment lowered serum transaminase enzymes, creatinine, and pro-inflammatory cytokines compared to the non-treated group.
- Histopathological analysis showed reduced tissue damage in AMP-treated mice compared to untreated controls.

## Abstract

due to the fact that antimicrobial peptides antimicrobial peptides (AMPs) from climbing perch have not been fully explored for their antimicrobial potency, this investigation was undertaken to explore that possibility.

antimicrobial peptides (AMPs) from the mucous secretion of climbing perch were obtained and an in-vivo analysis was conducted using mice.

the results showed inhibitory effects on multidrug-resistant multidrug-resistant Pseudomonas aeruginosa with reduced mortality from 100% among the non-treated group to 25%. Similarly, the level of serum transaminase enzymes (AST and ALT), creatinine levels, and pro-inflammatory cytokines (TNF-α and IL-6) were all found to be higher in the non-treatment group compared to the AMP-treatment group. Also, extensive tissue damage in the lung, liver, and spleen of the non-treated control group mice was observed based on the histopathological lesions recorded. As expected, AMPs from climbing perch significantly alleviated multidrug-resistant P. aeruginosa infection in-vivo and produced enhanced therapeutic efficacy superior to the ciprofloxacin treatment.

this study provides insight into the potential antimicrobial activity of fish innate immune system-derived peptides that could serve as a candidate for the substitute of antibiotics.

## Linked entities

- **Proteins:** ADSL (adenylosuccinate lyase), GOT1 (glutamic-oxaloacetic transaminase 1), GPT (glutamic--pyruvic transaminase), TNF (tumor necrosis factor), IL6 (interleukin 6)
- **Chemicals:** ciprofloxacin (PubChem CID 2764)
- **Species:** Pseudomonas aeruginosa (taxon 287), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, Slc17a5 (solute carrier family 17 (anion/sugar transporter), member 5) [NCBI Gene 235504] {aka 4631416G20Rik, 4732491M05, AST, ISSD, NSD, SD}
- **Diseases:** inflammatory (MESH:D007249), tissue damage (MESH:D017695)
- **Chemicals:** peptides (MESH:D010455), creatinine (MESH:D003404), AMP (MESH:D000089882), ciprofloxacin (MESH:D002939)
- **Species:** Anabas testudineus (climbing perch, species) [taxon 64144], Pseudomonas aeruginosa (species) [taxon 287], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10924623/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10924623/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC10924623/full.md

---
Source: https://tomesphere.com/paper/PMC10924623